Animal Studies Show Path for Zika Virus Vaccine in Humans

Share this content:
Animal Studies Show Path for Zika Virus Vaccine in Humans
Animal Studies Show Path for Zika Virus Vaccine in Humans

FRIDAY, Aug. 5, 2016 (HealthDay News) -- Three vaccine platforms have demonstrated protective efficacy against Zika virus (ZIKV) challenge in rhesus monkeys, according to research published online Aug. 4 in Science.

Noting that the development of a safe and effective ZIKV vaccine is an urgent global priority, Peter Abbink, from Harvard Medical School in Boston, and colleagues investigated three vaccine platforms that have been developed in order to protect against ZIKV challenge in rhesus monkeys.

The researchers found that a purified inactivated virus vaccine was able to induce ZIKV-specific neutralizing antibodies, and provided complete protection for monkeys against ZIKV strains from Brazil and Puerto Rico. A second approach using purified immunoglobulin from vaccinated monkeys was able to confer passive protection in adoptive transfer studies. In a third approach, a plasmid DNA vaccine and single-shot recombinant rhesus adenovirus serotype 52 vector expressing ZIKV prM-Env was able to elicit neutralizing antibodies; this also provided complete protection for monkeys against ZIKV challenge.

"These data support the rapid clinical development of ZIKV vaccines for humans," the authors write.

Three authors are employees of BIOQUAL.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Greater resolution of nodules with hyaluronidase versus saline; more rapid resolution with higher doses

Improvement in Race-Based Disparities in Years of Life Lost

Improvement in Race-Based Disparities in Years of Life ...

Decline in race-based disparities in years of life lost seen in the United States from 1990 to 2014

Drug-Related Endocarditis Cases Up From 2007 to 2015

Drug-Related Endocarditis Cases Up From 2007 to 2015

Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use

is free, fast, and customized just for you!

Already a member?

Sign In Now »